Stay updated with breaking news from Progressive Forms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis - read this article along with other careers information, tips and advice on BioSpace
PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION TO INITIATE THE CONFIRMATORY PHASE 3 STUDY WITH MASITINIB IN THE TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS...
Search jobs 10-Jan-2021 Atara Biotherapeutics Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annual J.P. Morgan Healthcare Conference Atara achieved significant progress across its three strategic priorities in 2020 Atara is well-positioned for success in anticipated tab-cel ® regulatory submissions, approval and launch Atara has had productive interactions with the FDA for ATA188 and is progressing the Phase 2 randomized clinical trial (RCT) toward an interim analysis in H1 2022 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WI...